ASFX — American Scientific Resources Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $6.16m
- $0.86m
Annual income statement for American Scientific Resources, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2010 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS PRELIM | PROSPECTUS PRELIM |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 0.735 | 0.862 |
| Cost of Revenue | ||
| Gross Profit | 0.307 | 0.107 |
| Selling / General / Administrative Expenses | ||
| Unusual Expense / Income | ||
| Total Operating Expenses | 2.42 | 6.28 |
| Operating Profit | -1.68 | -5.42 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -2.44 | -7.04 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -2.44 | -7.04 |
| Net Income Before Extraordinary Items | ||
| Net Income | -2.44 | -7.04 |
| Adjustments to Net Income | ||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Dilution Adjustment | ||
| Diluted Net Income | -3.42 | -7.04 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.22 | -0.3 |
| Dividends per Share |